Stockscreener 앱 받기
2.04
8.93%
-0.20
시간 외 거래:
2.00
-0.04
-1.96%
전일 마감가:
$2.24
열려 있는:
$2.44
하루 거래량:
1.51M
Relative Volume:
7.99
시가총액:
$10.85M
수익:
$755.00K
순이익/손실:
$-9.33M
주가수익비율:
-0.3573
EPS:
-5.71
순현금흐름:
$-5.43M
1주 성능:
-2.86%
1개월 성능:
-54.26%
6개월 성능:
-13.92%
1년 성능:
-51.84%
1일 변동 폭
$1.6262
$2.85
1주일 범위
$1.6262
$2.8752
52주 변동 폭
$1.485
$16.80
Mangoceuticals Inc Stock (MGRX) Company Profile
명칭
Mangoceuticals Inc
전화
(833) 626-4679
주소
15110 DALLAS PKWY, SUITE 600, DALLAS
MGRX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MGRX
Mangoceuticals Inc
|
2.04 | 10.85M | 755.00K | -9.33M | -5.43M | -5.71 |
|
VEEV
Veeva Systems Inc
|
220.53 | 35.90B | 2.75B | 714.14M | 1.09B | 4.33 |
|
DOCS
Doximity Inc
|
54.22 | 9.90B | 516.85M | 174.11M | 217.38M | 0.87 |
|
HQY
Healthequity Inc
|
86.08 | 7.46B | 1.15B | 96.70M | -161.99M | 1.09 |
|
TEM
Tempus Ai Inc
|
49.55 | 7.07B | 640.44M | -743.28M | -206.93M | -11.29 |
|
WAY
Waystar Holding Corp
|
36.80 | 6.32B | 906.14M | -52.62M | 89.62M | -0.3621 |
Mangoceuticals Inc 주식(MGRX)의 최신 뉴스
What to expect from Mangoceuticals Inc’s (MGRX) current quarter earnings? - uspostnews.com
CEO Spotlight: How Mangoceuticals Inc. is Reinventing The Personal Health Landscape - Corsicana Daily Sun
Mangoceuticals Disrupts $33B Health Market: 5 Revolutionary Products Including FDA-Approved Treatments - Stock Titan
Mangoceuticals Issues Bonus Shares to Leadership - MSN
Mangoceuticals (NASDAQ:MGRX) Trading Down 10.3% – Time to Sell? - Defense World
MGRX stock touches 52-week low at $1.79 amid market challenges By Investing.com - Investing.com South Africa
MGRX stock touches 52-week low at $1.79 amid market challenges - Investing.com Canada
Mangoceuticals issues new shares from preferred stock conversion - Investing.com India
Mangoceuticals issues new shares from preferred stock conversion By Investing.com - Investing.com South Africa
Mangoceuticals Inc (MGRX) Stock: Analyzing the Market Value - News Heater
Mangoceuticals Issues Common Stock in Exchange for Preferred - Investing.com Australia
Mangoceuticals Issues Common Stock in Exchange for Preferred By Investing.com - Investing.com India
Mangoceuticals stock hits 52-week low at $2.06 - Investing.com India
Mangoceuticals stock hits 52-week low at $2.06 By Investing.com - Investing.com Australia
Mangoceuticals Inc (NASDAQ: MGRX) Stock: Bulls Should Watch This - Stocks Register
Mangoceuticals Expands into $33 Billion Addressable - GlobeNewswire
Mangoceuticals enters master distribution agreement for Diabetinol rights - TipRanks
Mangoceuticals Expands into $33 Billion Addressable Diabetes Market Through its Exclusive Rights to Market and Sell Patented and Clinically Proven Diabetinol® in the USA and Canada - GlobeNewswire
Major Diabetes Market Breakthrough: Mangoceuticals Launches GLP-1 Alternative at Fraction of Cost - Stock Titan
Mangoceuticals Inc. (MGRX) reports earnings - Quartz
MANGOCEUTICALS, INC. SEC 10-K Report - TradingView
Mangoceuticals (NASDAQ:MGRX) Shares Up 18% – Time to Buy? - Defense World
Mangoceuticals Announces Equity and Leadership Changes By Investing.com - Investing.com Australia
Mangoceuticals, Inc. Approves Key Amendments at Special Meeting - TipRanks
Mangoceuticals Announces Equity and Leadership Changes - Investing.com
Mangoceuticals advances in H1N1 and H5N1 studies - MSN
Mangoceuticals, Inc. Now Featured on Webull Corporate Communications Service Platform - ACCESS Newswire
Shares of Healthcare Company Rise Following Product Availability Announcement - MSN
Mangoceuticals Launches PeachesRx, A Women's Telehealth Brand For Wellness And GLP-1 Treatments - Nasdaq
Mangoceuticals Announces the Launch of “PeachesRx”a - GlobeNewswire
Mangoceuticals rises on launch of women's telehealth brand - TradingView
Mangoceuticals launches PeachesRx women’s telehealth brand - TipRanks
This New Women's Health Platform Could Disrupt the $48B GLP-1 Weight Loss Market - StockTitan
Mangoceuticals Inc. issues stock for consulting services By Investing.com - Investing.com South Africa
Mangoceuticals Inc. issues stock for consulting services - Investing.com
Mangoceuticals (MGRX): A Low Float Stock on the Verge of a Short Squeeze? - Small Cap Exclusive
Mangoceuticals (NASDAQ:MGRX) versus Quipt Home Medical (NASDAQ:QIPT) Head to Head Analysis - Defense World
Mangoceuticals targets avian flu with water-based solution By Investing.com - Investing.com Nigeria
Mangoceuticals Advances Research on Avian Flu Treatment for Poultry Industry - Defense World
Mangoceuticals targets avian flu with water-based solution - MSN
Mangoceuticals, Inc. Advances Antiviral Research on its Patented Respiratory Illness Prevention Technology - Marketscreener.com
Mangoceuticals Advances Research On Avian Flu Solution For Poultry -February 12, 2025 at 08:19 am EST - Marketscreener.com
Mangoceuticals Advances Antiviral Research on its Patented - GlobeNewswire
Mangoceuticals Inc (MGRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.12%
2.04%
자본화:
|
볼륨(24시간):